Search
for
Sort by
Research 151–180 of 1000+
- History as a Tool in Identifying “New” Old Drugs
- Emerging drugs for hypogonadism
- Smart stimuli-responsive microneedle platforms for precision androgenetic alopecia therapy: Materials strategy and therapeutic perspectives
- Abstract 13315: Recurrent Cardiac Tamponade Due to Minoxidil Associated Drug Induced Lupus Erythematosus
- Nanotechnology-Based Strategies for Hair Follicle Regeneration in Androgenetic Alopecia
- Role of Drug Repurposing in Sustainable Drug Discovery
- Validation of scalp coverage scoring methods for scalp hair loss in male pattern hair loss (androgenetic alopecia)
- The novel drug CS-891 inhibits 5alpha-reductase activity in freshly isolated dermal papilla of human hair follicles.
- Research and application of digital technology in the diagnosis and treatment of androgenetic alopecia
- Comprehensive Strategies for the Management of Androgenetic Alopecia: From Conventional Therapies to Nanotechnology and Regenerative Approaches
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES
- Development and validation of a comprehensive in vitro organ model for androgenetic alopecia
- Molecular Docking Studies and ADME-Tox Prediction of Phytocompounds from Lycopersicon esculentum mill. as a Drug Candidate for Alopecia Treatment
- Development and Characterization of Film Forming Spray of 5% Minoxidil for Baldness Due to Androgenetic Alopecia
- Drug News
- The etiology of androgenetic alopecia:An analysis of 240 cases
- Myocyte Androgen Receptor Modulates Body Composition and Metabolic Parameters
- Drug Therapy in Polycystic Ovarian Syndrome
- Drug points: Topical minoxidil for common baldness
- Hair Growth Therapy(ies) for Androgenetic Alopecia
- Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues